🇺🇸 FDA
Patent

US 7354912

Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity

granted A61KA61K31/66A61K31/663

Quick answer

US patent 7354912 (Unique compositions of zwitterionic phospholipids and bisphosphonates and use of the compositions as bisphosphate delivery systems with reduced GI toxicity) held by The Board of Regents of the University of Texas System expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/66, A61K31/663, A61K31/685, A61K33/00